This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04152/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04152/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB04152/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04152/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04152/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04152
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB04152 n14:DB04152
dcterms:title
2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid
adms:identifier
n9:46507460 n10:IBC n11:5288598 n12:21377145 n13:DB04152
n5:IUPAC-Name
n6:271B3F21-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B3F27-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B3F26-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B3F23-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B3F24-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B3F25-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B3F1F-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B3F20-363D-11E5-9242-09173F13E4C5 n6:271B3F1D-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B3F1E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B3F2D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B3F2E-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B3F28-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B3F29-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B3F2B-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B3F2A-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B3F2C-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B3F33-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B3F35-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B3F36-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B3F32-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B3F31-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B3F34-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B3F22-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B3F2F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B3F30-363D-11E5-9242-09173F13E4C5